Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,968 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antiemetic efficacy and safety of a combination of palonosetron, aprepitant, and dexamethasone in patients with testicular germ cell tumor receiving 5-day cisplatin-based combination chemotherapy.
Hamada S, Hinotsu S, Kawai K, Yamada S, Narita S, Kamba T, Nishiyama H, Arai Y, Habuchi T, Ogawa O, Kawakami K. Hamada S, et al. Among authors: kawai k. Support Care Cancer. 2014 Aug;22(8):2161-6. doi: 10.1007/s00520-014-2182-7. Epub 2014 Mar 21. Support Care Cancer. 2014. PMID: 24652048 Clinical Trial.
The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor.
Takizawa A, Kawai K, Kawahara T, Kojima T, Maruyama S, Shinohara N, Akamatsu S, Kamba T, Nakamura T, Ukimura O, Jikuya R, Kishida T, Kakimoto K, Nishimura K, Harabayashi T, Nagamori S, Yamashita S, Arai Y, Sawada Y, Sekido N, Kinoshita H, Matsuda T, Nakagawa T, Homma Y, Nishiyama H. Takizawa A, et al. Among authors: kawai k. J Cancer Res Clin Oncol. 2018 Jan;144(1):109-115. doi: 10.1007/s00432-017-2520-5. Epub 2017 Sep 13. J Cancer Res Clin Oncol. 2018. PMID: 28905168
Validation study of the Japanese version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Testicular Cancer 26 for patients with testicular cancer.
Yamashita S, Suzukamo Y, Kakimoto K, Uemura M, Kishida T, Kawai K, Nakamura T, Goto T, Osawa T, Yamada S, Nishimura K, Nonomura N, Nishiyama H, Shiraishi T, Ukimura O, Ogawa O, Shinohara N, Ito A, Arai Y. Yamashita S, et al. Among authors: kawai k. Int J Urol. 2021 Feb;28(2):176-182. doi: 10.1111/iju.14422. Epub 2020 Nov 10. Int J Urol. 2021. PMID: 33174259
Health-Related Quality of Life in Testicular Cancer Survivors in Japan: A Multi-Institutional, Cross-Sectional Study Using the EORTC QLQ-TC26.
Yamashita S, Kakimoto K, Uemura M, Kishida T, Kawai K, Nakamura T, Goto T, Osawa T, Yamada S, Nishimura K, Nonomura N, Nishiyama H, Shiraishi T, Ukimura O, Ogawa O, Shinohara N, Suzukamo Y, Ito A, Arai Y. Yamashita S, et al. Among authors: kawai k. Urology. 2021 Oct;156:173-180. doi: 10.1016/j.urology.2021.02.039. Epub 2021 Mar 27. Urology. 2021. PMID: 33785401
Fertility and reproductive technology use in testicular cancer survivors in Japan: A multi-institutional, cross-sectional study.
Yamashita S, Kakimoto K, Uemura M, Kishida T, Kawai K, Nakamura T, Goto T, Osawa T, Yamada S, Nishimura K, Nonomura N, Kojo K, Shiraishi T, Ukimura O, Ogawa O, Shinohara N, Suzukamo Y, Ito A, Arai Y. Yamashita S, et al. Among authors: kawai k. Int J Urol. 2021 Oct;28(10):1047-1052. doi: 10.1111/iju.14645. Epub 2021 Jul 18. Int J Urol. 2021. PMID: 34278620
Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo-refractory germ cell tumors.
Kawahara T, Kawai K, Kojima T, Nagumo Y, Sakka S, Kandori S, Negoro H, Mathis BJ, Maruo K, Miura K, Sakamoto N, Shinohara N, Yamashita S, Yonemori K, Kishida T, Ukimura O, Nishimura K, Kobayashi Y, Nishiyama H. Kawahara T, et al. Among authors: kawai k. Int J Urol. 2022 Jul;29(7):741-747. doi: 10.1111/iju.14885. Epub 2022 Apr 23. Int J Urol. 2022. PMID: 35462438 Free PMC article. Clinical Trial.
Association of financial toxicity with quality of life in testicular cancer survivors.
Nezu K, Yamashita S, Kakimoto K, Uemura M, Kishida T, Kawai K, Nakamura T, Goto T, Osawa T, Nishimura K, Nonomura N, Negoro H, Shiraishi T, Ukimura O, Ogawa O, Shinohara N, Suzukamo Y, Ito A, Arai Y. Nezu K, et al. Among authors: kawai k. Int J Urol. 2022 Dec;29(12):1526-1534. doi: 10.1111/iju.15039. Epub 2022 Sep 14. Int J Urol. 2022. PMID: 36102302
3,968 results